AMY PEREZ: Open Payments
NPI 1235597808 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 5 payments from 4 companies in 2025. Trend: 2023 $476 · 2024 $17 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $168 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Novo Nordisk Inc | 2 | $40 |
| MDD US Operations, LLC | 1 | $24 |
Products named: AMPLATZER AMULET, Symbravo, Wegovy, Qelbree.
Industry payments across GA — which companies pay providers there.
